These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25668817)

  • 1. Plasmin releases the anti-tumor peptide from the NC1 domain of collagen XIX.
    Oudart JB; Brassart-Pasco S; Vautrin A; Sellier C; Machado C; Dupont-Deshorgue A; Brassart B; Baud S; Dauchez M; Monboisse JC; Harakat D; Maquart FX; Ramont L
    Oncotarget; 2015 Feb; 6(6):3656-68. PubMed ID: 25668817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type XIX collagen: A new partner in the interactions between tumor cells and their microenvironment.
    Oudart JB; Monboisse JC; Maquart FX; Brassart B; Brassart-Pasco S; Ramont L
    Matrix Biol; 2017 Jan; 57-58():169-177. PubMed ID: 27491275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NC1 domain of type XIX collagen inhibits melanoma cell migration.
    Toubal A; Ramont L; Terryn C; Brassart-Pasco S; Patigny D; Sapi J; Monboisse JC; Maquart FX
    Eur J Dermatol; 2010; 20(6):712-8. PubMed ID: 20840910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anti-tumor NC1 domain of collagen XIX inhibits the FAK/ PI3K/Akt/mTOR signaling pathway through αvβ3 integrin interaction.
    Oudart JB; Doué M; Vautrin A; Brassart B; Sellier C; Dupont-Deshorgue A; Monboisse JC; Maquart FX; Brassart-Pasco S; Ramont L
    Oncotarget; 2016 Jan; 7(2):1516-28. PubMed ID: 26621838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The NC1 domain of type XIX collagen inhibits in vivo melanoma growth.
    Ramont L; Brassart-Pasco S; Thevenard J; Deshorgue A; Venteo L; Laronze JY; Pluot M; Monboisse JC; Maquart FX
    Mol Cancer Ther; 2007 Feb; 6(2):506-14. PubMed ID: 17308049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical methods for measuring collagen XIX in human cell cultures, tissue extracts, and biological fluids.
    Oudart JB; Brassart-Pasco S; Luczka E; Dupont-Deshorgue A; Bellon G; Boudko SP; Bächinger HP; Monboisse JC; Maquart FX; Ramont L
    Anal Biochem; 2013 Jun; 437(2):111-7. PubMed ID: 23499763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type XIX collagen: a promising biomarker from the basement membranes.
    Calvo AC; Moreno L; Moreno L; Toivonen JM; Manzano R; Molina N; de la Torre M; López T; Miana-Mena FJ; Muñoz MJ; Zaragoza P; Larrodé P; García-Redondo A; Osta R
    Neural Regen Res; 2020 Jun; 15(6):988-995. PubMed ID: 31823868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis].
    Kobayashi H
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):623-32. PubMed ID: 8808830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antitumor properties of the alpha3(IV)-(185-203) peptide from the NC1 domain of type IV collagen (tumstatin) are conformation-dependent.
    Floquet N; Pasco S; Ramont L; Derreumaux P; Laronze JY; Nuzillard JM; Maquart FX; Alix AJ; Monboisse JC
    J Biol Chem; 2004 Jan; 279(3):2091-100. PubMed ID: 14583633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endostatins derived from collagens XV and XVIII differ in structural and binding properties, tissue distribution and anti-angiogenic activity.
    Sasaki T; Larsson H; Tisi D; Claesson-Welsh L; Hohenester E; Timpl R
    J Mol Biol; 2000 Sep; 301(5):1179-90. PubMed ID: 10966814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure, function and tissue forms of the C-terminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatin.
    Sasaki T; Fukai N; Mann K; Göhring W; Olsen BR; Timpl R
    EMBO J; 1998 Aug; 17(15):4249-56. PubMed ID: 9687493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant alpha2(IV)NC1 domain inhibits tumor cell-extracellular matrix interactions, induces cellular senescence, and inhibits tumor growth in vivo.
    Roth JM; Akalu A; Zelmanovich A; Policarpio D; Ng B; MacDonald S; Formenti S; Liebes L; Brooks PC
    Am J Pathol; 2005 Mar; 166(3):901-11. PubMed ID: 15743801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type XIX collagen purified from human umbilical cord is characterized by multiple sharp kinks delineating collagenous subdomains and by intermolecular aggregates via globular, disulfide-linked, and heparin-binding amino termini.
    Myers JC; Li D; Amenta PS; Clark CC; Nagaswami C; Weisel JW
    J Biol Chem; 2003 Aug; 278(34):32047-57. PubMed ID: 12788917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural analysis of the heparin-binding site of the NC1 domain of collagen XIV by CD and NMR.
    Montserret R; Aubert-Foucher E; McLeish MJ; Hill JM; Ficheux D; Jaquinod M; van der Rest M; Deléage G; Penin F
    Biochemistry; 1999 May; 38(20):6479-88. PubMed ID: 10350466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrikines in the regulation of extracellular matrix degradation.
    Maquart FX; Bellon G; Pasco S; Monboisse JC
    Biochimie; 2005; 87(3-4):353-60. PubMed ID: 15781322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trimerization and triple helix stabilization of the collagen XIX NC2 domain.
    Boudko SP; Engel J; Bächinger HP
    J Biol Chem; 2008 Dec; 283(49):34345-51. PubMed ID: 18845531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical and immunohistochemical characterization of human type XIX defines a novel class of basement membrane zone collagens.
    Myers JC; Li D; Bageris A; Abraham V; Dion AS; Amenta PS
    Am J Pathol; 1997 Dec; 151(6):1729-40. PubMed ID: 9403723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New functional roles for non-collagenous domains of basement membrane collagens.
    Ortega N; Werb Z
    J Cell Sci; 2002 Nov; 115(Pt 22):4201-14. PubMed ID: 12376553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basement membrane type IV collagen degradation: evidence for the involvement of a proteolytic cascade independent of metalloproteinases.
    Mackay AR; Corbitt RH; Hartzler JL; Thorgeirsson UP
    Cancer Res; 1990 Sep; 50(18):5997-6001. PubMed ID: 2144209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane.
    Liotta LA; Goldfarb RH; Brundage R; Siegal GP; Terranova V; Garbisa S
    Cancer Res; 1981 Nov; 41(11 Pt 1):4629-36. PubMed ID: 6458354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.